Krishnan Sampath

Chief Technology Officer (invetx * A Dechra Division) at Invetx

Krishnan has 20+ years of technical and leadership experience in biologics CMC development and manufacturing of novel biologics and biosimilars including cytokines, monoclonal antibodies, bispecifics, antibody-drug conjugates, peptibodies, and Fc fusion proteins.

He supported 20+ IND stage programs, multiple BLA regulatory filings and successful approvals of human biotherapeutics products.

Links